Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Advanced Technologies for Antigen Identification
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Advanced Technologies for Antigen Identification
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Cancer Immunity, an open access journal of the Cancer Research Institute

Articles

  • Articles
    Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice
    Emma Jones, Michaela Dahm-Vicker, Anna Katharina Simon, Angharad Green, Fiona Powrie, Vincenzo Cerundolo and Awen Gallimore
    Cancer Immun January 1 2002 2 (1)

  • Articles
    CD40 triggering increases the efficiency of dendritic cells for antitumoral immunization
    Naïma Mazouz, Annie Ooms, Véronique Moulin, Sonja Van Meirvenne, Catherine Uyttenhove and Gérard Degiovanni
    Cancer Immun January 1 2002 2 (1)

  • Articles
    In vitro generated cytolytic T lymphocytes reactive against head and neck cancer recognize multiple epitopes presented by HLA-A2, including peptides derived from the p53 and MDM-2 proteins
    Tadao Asai, Walter J. Storkus, Jan Mueller-Berghaus, William Knapp, Albert B. DeLeo, Kazuaki Chikamatsu and Theresa L. Whiteside
    Cancer Immun January 1 2002 2 (1)

  • Articles
    Immunization against a dominant tumor antigen abrogates immunogenicity of the tumor
    Amira Makki, Gunnar Weidt, Nathalie E. Blachere, Leo Lefrançois and Pramod K. Srivastava
    Cancer Immun January 1 2002 2 (1)

  • Articles
    Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum
    Dirk Jäger, Marc Unkelbach, Claudia Frei, Florian Bert, Matthew J. Scanlan, Elke Jäger, Lloyd J. Old, Yao-Tseng Chen and Alexander Knuth
    Cancer Immun January 1 2002 2 (1)

  • Articles
    T-cell response to unique and shared antigens and vaccination of cancer patients
    Giorgio Parmiani, Marialuisa Sensi, Chiara Castelli, Licia Rivoltini and Andrea Anichini
    Cancer Immun January 1 2002 2 (1)

  • Articles
    Functional analysis of HLA-A*0201/Melan-A peptide multimer+ CD8+ T cells isolated from an HLA-A*0201- donor: exploring tumor antigen allorestricted recognition
    Valérie Dutoit, Philippe Guillaume, Pedro Romero, Jean-Charles Cerottini and Danila Valmori
    Cancer Immun January 1 2002 2 (1)

  • Articles
    Induction of autoantibodies against tyrosinase-related proteins following DNA vaccination: Unexpected reactivity to a protein paralogue
    Roopa Srinivasan, Alan N. Houghton and Jedd D. Wolchok
    Cancer Immun January 1 2002 2 (1)

  • Articles
    Identification of a new peptide recognized by autologous cytolytic T lymphocytes on a human melanoma
    Nathalie Vigneron, Annie Ooms, Sandra Morel, Gérard Degiovanni and Benoît J. Van den Eynde
    Cancer Immun January 1 2002 2 (1)

  • Articles
    Urine antibody against human cancer antigen NY-ESO-1
    Dirk Jäger, Elisabeth Stockert, Julia Karbach, Kristina Herrlinger, Akin Atmaca, Michael Arand, Yao-Tseng Chen, Sacha Gnjatic, Lloyd J. Old, Alexander Knuth and Elke Jäger
    Cancer Immun January 1 2002 2 (1)

  • Articles
    Expression of cancer-testis genes in human hepatocellular carcinomas
    Guorong Luo, Shaoming Huang, Xiaoxun Xie, Elisabeth Stockert, Yao-Tseng Chen, Boris Kubuschok and Michael Pfreundschuh
    Cancer Immun January 1 2002 2 (1)

  • Articles
    Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51
    Elke Jäger, Julia Karbach, Sacha Gnjatic, Dirk Jäger, Markus Maeurer, Akin Atmaca, Michael Arand, Jonathan Skipper, Elisabeth Stockert, Yao-Tseng Chen, Lloyd J. Old and Alexander Knuth
    Cancer Immun January 1 2002 2 (1)

  • Articles
    Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871
    Zhanqi Liu, Fook-Thean Lee, Nobuo Hanai, Fiona E. Smyth, Antony W. Burgess, Lloyd J. Old and Andrew M. Scott
    Cancer Immun January 1 2002 2 (1)

  • Articles
    Characterization of cells prepared by dendritic cell-tumor cell fusion
    Eva Gottfried, René Krieg, Christian Eichelberg, Reinhard Andreesen, Andreas Mackensen and Stefan W. Krause
    Cancer Immun January 1 2002 2 (1)

  • Articles
    Naturally formed or artificially reconstituted non-covalent alpha2-macroglobulin-peptide complexes elicit CD91-dependent cellular immunity
    Robert J. Binder, Sumeet K. Kumar and Pramod K. Srivastava
    Cancer Immun January 1 2002 2 (1)

Commentary

  • Commentary
    Can hTERT peptide540-548-specific CD8 T cells recognize and kill tumor cells?
    Daniel E. Speiser, Jean-Charles Cerottini and Pedro Romero
    Cancer Immun January 1 2002 2 (1)

Back to top
PreviousNext
Cancer Immunity Archive: 2 (1)
January 2002
Volume 2, Issue 1
  • Table of Contents

Sign up for alerts

Jump to

  • Articles
  • Commentary
Advertisement
  • Most Cited
  • Most Read
Loading
  • Activity of Anti-CTLA-4 Isotypes in Antitumor Responses
  • Masters of Immunology
  • Extending Reach of Checkpoint Blockade in Pancreatic Cancer
  • Characterization of Murine Syngeneic Tumor Models
  • Case Report: RNA CAR T Cells
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement